We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

150 hedge funds and large institutions have $318M invested in PDL BioPharma, Inc. in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 63 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

206% more call options, than puts

Call options by funds: $459K | Put options by funds: $150K

63% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 16

49% more capital invested

Capital invested by funds: $214M → $318M (+$104M)

7% more funds holding

Funds holding: 140150 (+10)

48% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 63

Holders
150
Holders Change
+10
Holders Change %
+7.14%
% of All Funds
2.96%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
33
Reduced
63
Closed
16
Calls
$459K
Puts
$150K
Net Calls
+$309K
Net Calls Change
+$165K
Name Holding Trade Value Shares
Change
Change in
Stake
Mackenzie Financial
151
Mackenzie Financial
Ontario, Canada
-$78K -36,000 Closed
QT
152
Quantbot Technologies
New York
-$72K -33,578 Closed
BCM
153
BlueCrest Capital Management
Jersey
-$58K -26,750 Closed
VF
154
Virtu Financial
New York
-$47K -21,796 Closed
BCA
155
Bray Capital Advisors
Florida
-$4K -1,859 Closed
WT
156
Whittier Trust
California
-$3.66K -1,260 -98%
AF
157
Advisornet Financial
Minnesota
-$1K -400 Closed
GI
158
Gradient Investments
Minnesota
-$1K -263 Closed
AF
159
Allworth Financial
California
+$290 +100 New